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Low-dose CT coronary angiography
for the prediction of myocardial ischaemia
Abstract The purpose of this study
was to prospectively determine the
accuracy of low-dose computed
tomography coronary angiography
(CTCA) for the diagnosis of func-
tionally relevant coronary artery dis-
ease (CAD) using cardiac magnetic
resonance (CMR) as a standard of
reference. Forty-one consecutive pa-
tients (age 64±10 years) underwent
k-space and time broad-use linear
acquisition speed-up technique accel-
erated CMR (1.5 T) and dual-source
CTCA using prospective electrocar-
diography gating within 1 day. CTCA
lesions were analysed and diameter
stenoses of more than 50% and more
than 75% were compared with CMR
findings taken as the reference stan-
dard for assessing the functional
relevance of CAD. CMR revealed
perfusion defects in 21/41 patients
(51%). A total of 569 coronary seg-
ments were analysed with low-dose
CTCA. The image quality of low-dose
CTCA was diagnostic in 566/569
segments (99.5%) in 39/41 patients
(95%). Low-dose CTCA revealed
stenoses of more than 50% in 58/123
coronary arteries (47.2%) in 24/41
patients (59%) and more than 75%
stenoses in 46/123 coronary arteries
(37.4%) in 23/41 patients (56%).
Using a greater than 50% diameter
stenosis, low-dose CTCA yielded the
following per artery sensitivity, spec-
ificity, positive and negative predic-
tive values, and accuracy for the
detection of perfusion defects: 89%,
79%, 72%, 92% and 83%, respec-
tively. Low-dose CTCA is reliable for
ruling out functionally relevant CAD,
but is a poor predictor of myocardial
ischaemia.
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Introduction
Myocardial perfusion imaging using either single-photon
emission computed tomography (SPECT) or cardiac
magnetic resonance (CMR) is an established method for
the noninvasive functional assessment of coronary artery
disease (CAD). When compared with conventional coro-
nary angiography, recent studies have revealed CMR to
have similar [1] or even higher [2–4] diagnostic accuracy
compared with that achieved with SPECT [2–4] or gated
SPECT [1], with no radiation exposure to the patients.
Contrary to the purely anatomical information provided by
invasive catheter angiography (ICA) and computed tomog-
raphy coronary angiography (CTCA), perfusion imaging
allows for the evaluation of the functional significance of
coronary stenoses and provides prognostic information for
risk stratification [5–7].
CTCA has emerged as a robust and accurate tool for the
noninvasive evaluation of CAD [8–11]. Because of
concerns regarding the radiation exposure of patients
undergoing CTCA, a number of dose-reducing methods
have been developed [12, 13]. One of the most efficient
techniques for radiation dose reduction in CTCA is
prospective electrocardiography (ECG) gating [14–16].
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With this technique, radiation is only delivered at
predefined time points of the cardiac cycle, rather than
during the entire cardiac cycle, as with the retrospective
ECG gating technique. Initial studies have shown that low-
dose CTCA is accurate for diagnosing coronary stenoses in
comparison with ICA [17]. Concerning functional in-
formation, 64-section CTCAwas already evaluated against
SPECT and helped in ruling out haemodynamically
relevant CAD [18]; however, there are no data on the
diagnostic performance of low-dose CTCA for the
prediction of ischaemia in comparison to CMR.
Thus, we aimed to prospectively determine the accuracy
of low-dose CTCA for the detection of functionally
relevant CAD as determined by CMR.
Materials and methods
Study population
The study was conducted prospectively, enrolling 80
consecutive patients who had undergone CTCA because
of suspected CAD. The patient demographics are sum-
marised in Table 1. Exclusion criteria for low-dose CTCA
were impaired renal function (creatinine level above
120 μmol/L, n=1), known hypersensitivity to contrast
medium (n=0) and absolute arrhythmia (n=0). Scanning
with prospective ECG triggering was not performed in
patients with hearts rates of 70 bpm or higher (n=4). These
four patients were examined with a retrospectively ECG
gated CT protocol but excluded from this study. Patients
with previous stent graft placement (n=14) or bypass
surgery (n=5) as well as history of previous myocardial
infarction (n=8) were excluded from the study. All
remaining patients (n=48) were asked to participate in
this study comparing CTCA with CMR. Patients were
excluded from CMR if they presented contraindications to
adenosine (second or third AV block, sick sinus syndrome,
symptomatic bradycardia, severe asthma or obstructive
pulmonary disease; n=1), or to MR (implanted electronic
devices, metallic foreign bodies in the eye, severe claus-
trophobia, and others according to local regulations and
manufacturer’s recommendations; n=6). Thus, a total of 41
patients could be included in this study (Fig. 1). According
to the criteria published by Diamond and Forrester [19],
each patient in this population had an intermediate (n=31)
to high (n=10) pretest probability of CAD. This method
uses age, sex and symptoms to stratify risk into three
categories. Patients with a pretest probability below 13.4%
were categorized as low probability and those with a pretest
probability above 87.2% were categorized as high proba-
bility. Those that fell between these limits would be
categorized as intermediate probability (Table 1). All
CTCA and CMR examinations were performed within
1 day.
The study protocol was approved by the local ethics
committee and written informed consent was obtained
from all patients.
Low-dose CTCA
All CT examinations were performed on a dual-source CT
machine (Somatom Definition, Siemens Healthcare, For-
chheim, Germany) using prospective ECG gating. All
patients received a single 2.5-mg dose of sublingual
isosorbide dinitrate (Isoket, Schwarz Pharma). No beta-
blockers were given before CT. Eighty to 100 ml of
contrast medium (iopromide, Ultravist 370, Bayer Scher-
ing Pharma, Berlin, Germany) was administered at a flow
rate of 5–6 ml/s, followed by 50 ml of a 20% contrast
agent/80% saline solution mixture. Contrast agent was
applied using a dual-head power injector (Stellant, Medrad,
Indianola, USA) and was controlled by bolus tracking
using a region-of-interest in the ascending aorta (attenua-
tion threshold 120 HU). Data were acquired in the
craniocaudal direction during mid-inspiration using the
parameters: detector collimation 2×32×0.6 mm, slice
acquisition 2×64×0.6 mm by means of a z-flying spot,
gantry rotation time 0.33 s. Attenuation-based tube current
modulation was used with a reference tube current–time
product set at 190 mAs per rotation. The data acquisition
window was set at 70% of the R–R interval; the temporal
resolution was 83 ms. Patients with a body mass index
(BMI) of 25 kg/m2 (n=28) or above were examined with
a tube voltage of 120 kV; patients with a BMI below
Table 1 Patient demographics (n=42)
Men 36 (88%)
Women 5 (12%)
Age (years) 64±10 (41–77)
Body mass index (kg/m2) 28±4
Obesitya 10 (24%)
Cardiovascular risk factors
Hypertension 24 (59%)
Nicotine abuse 12 (29%)
Hyperlipidaemia 13 (32%)
Diabetes 4 (10%)
Family history 6 (15%)
Symptoms
Nonanginal chest pain 17 (42%)
Atypical angina 11 (27%)
Typical angina 13 (31%)
Pretest probability of CAD
Intermediate 31 (76%)
High 10 (24%)
CAD coronary artery disease
aDefined as a body mass index ≥30 kg/m2
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25 kg/m2 (n=13) with 100 kV. Low-dose CTCA images
were reconstructed in a monosegment mode with a slice
thickness of 0.6 mm, using a medium-smooth tissue
convolution kernel (B30f). If the vessel segment was
calcified, additional reconstructions were performed using
a sharp tissue convolution kernel (B45f) to compensate for
blooming artefacts. All images were anonymised and
transferred to an external workstation (Multi-Modality
Workplace, Siemens Healthcare) for analysis.
Low-dose CTCA data analysis
Low-dose CTCA data analysis was performed by two
independent radiologists who were both blinded to the
clinical history and to the results from any other test
(including CMR). All images were evaluated using trans-
verse source images and multiplanar reformations. All
segments with a diameter of 1 mm or greater at their origin
were included. Vessel segments distal to occlusions were
excluded from analysis.
Coronary segments were defined according to a
scheme proposed by the American Heart Association
[20]. Both the left main stem (segment 5) as well as the
intermediate artery (segment 16), if present, were
considered to belong to the left anterior descending
coronary artery (LAD).
First, both readers independently rated the image quality
of each coronary segment as being diagnostic or non-
diagnostic. Reasons for nondiagnostic image quality were
assigned to motion or stair-step artefacts, image noise,
severe vessel wall calcifications or insufficient contrast
attenuation.
Then, both readers independently evaluated all coronary
segments for the presence or absence of significant
stenoses, defined as luminal diameter narrowing of more
than 50% and more than 75%, respectively. All diameter
measurements were performed with an electronic calliper
tool on reconstructions perpendicularly oriented to the
vessel’s centerline. In the case of disagreement, a
consensus reading was appended 1 week after the initial
readout.
Fig. 1 Flowchart of the study
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CMR
All MR studies were performed on a 1.5-T clinical MR
system (Achieva, Philips Medical Systems, Best, the
Netherlands). Dedicated cardiac phased-array receiver
coils were used for signal reception (five elements). All
data were acquired during breath hold in end-inspiration.
The true short axis of the left ventricle was determined
from a series of scout images. Three representative short-
axis sections were obtained, one each in the basal, mid-
ventricular and apical regions of the left ventricle according
to the standardised 17-segment model of the American
Heart Association [21]. Pharmacological stress was applied
using adenosine, which was administered intravenously at
140 μg per kilogram of body weight over 2.5 min under
ECG, oxygen saturation, and blood pressure monitoring.
Acquisition of perfusion images was started immediately
after the injection of gadoterate meglumine (Gd-DOTA)
(Dotarem; Guerbet Research, Aulnay-sous-Bois, France).
Contrast medium was dosed at 0.1 mmol per kilogram of
body weight using a power injector (MR Spectris; Medrad,
Pittsburgh, PA) at an injection rate of 5 ml/s, followed by a
40-ml saline flush. Ten minutes after stress perfusion
imaging, a second bolus of 0.1 mmol gadoterate meglu-
mine was injected and rest perfusion images were obtained
with the same orientation and position before and after the
administration of adenosine. A delay of 10 min after the
stress examination allowed residual gadopentetate dime-
glumine to be washed out from the myocardium. SENSE
(k-t sensitivity encoding) imaging was used in combination
with a saturation recovery gradient-echo pulse sequence for
both of these sequences (repetition time/echo time
3.1/1.1 ms, flip angle 20°, saturation prepulse delay
110 ms, partial Fourier sampling, acquisition window
120 ms, section thickness 10 mm, k-t factor of 5 with 11 k-t
interleaved training profiles, effective acceleration 3.7,
three sections acquired sequentially during a single R–R
interval), as previously shown [22–24]. High spatial
resolution perfusion CMR was performed with an in-
plane resolution of 1.25×1.25 mm.
Ten minutes after rest perfusion, late gadolinium enhance-
ment images were acquired in a continuous short-axis view
using an inversion-recovery gradient-recalled echo MR
sequence with the following parameters: field of view 350–
400mm, repetition time/echo time 7.4/4.3ms, inversion time
200–350 ms, flip angle 20°, matrix 240×240, slice thickness
10 mm. The inversion time was chosen to minimise the
signal from normal myocardium.
CMR data analysis
CMR data analysis was performed by two different,
independent radiologists who were both blinded to the
clinical history and to the results from any other test
(including low-dose CTCA). In the case of disagreement
between the readers, a consensus reading was appended
within 1 week.
Rest and stress perfusion as well as late gadolinium
enhancement MR data were evaluated by visual analysis
for each patient according to a 16-segment model (the 17-
segment American Heart Association model [21] minus the
apical segment).
The following algorithm was used to define myocardial
segments presenting a perfusion defect: Segments were
considered to have a perfusion defect if (a) late gadolinium
enhancement was present and/or (b) a perfusion deficit was
found in stress perfusion but not in rest perfusion [25]. In
each case of disagreement between the readers, a consensus
was obtained, thereby getting dichotomic values for
presence of perfusion defects (0 = normal; 1= abnormal).
Myocardial territories were assigned to the three major
coronary arteries according to standard definitions [21].
Statistical analysis
Quantitative data are expressed as mean ± standard
deviation. Qualitative data are given in proportions. As
the assignment of single coronary segments on CT to
myocardial territories on CMR is not feasible, data
analyses were performed on a per artery (left anterior
descending coronary artery, LAD; left circumflex artery,
LCX; right coronary artery, RCA) and per patient basis, as
previously described [26]. Nondiagnostic segments at
CTCA were censored as positive findings in the vessel-
based and patient-based analyses, reflecting the intention-
to-diagnose nature of the study. We also added per patient
analysis as this provides the clinically most meaningful
information for patient management. Both analyses were
separately performed for diameter stenoses of more than
50% and more than 75%.
The unweighted κ statistic with binary data was used to
assess inter-reader variability, assessing low-dose CTCA
and CMR. κ values less than 0.4 indicated positive but poor
agreement, 0.41–0.75 good agreement and above 0.76
excellent agreement.
Sensitivity, specificity, negative predictive value (NPV),
positive predictive value (PPV) and accuracy including
95% confidence intervals were calculated for both lesion
degrees as mentioned above from χ2 tables of contingency
with CMR as the standard of reference. Statistical analyses
were performed using commercially available software
(SPSS, release 15.0, Inc., Chicago, IL).
Results
Low-dose CTCA
Low-dose CTCA examinations were performed success-
fully in all patients without complications. All patients
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were in sinus rhythm, and mean heart rate during CT was
60±7 bpm (range 43–69 bpm). The average effective
radiation dose per patient was 3.9±1.4 mSv.
Of the 656 theoretically possible coronary artery
segments (16 segments x 41 patients), 81 segments
(12.3%) were not present or were less than 1 mm in
diameter at their origin; six (0.9%) segments were located
distal to coronary artery occlusion. Hence, 569 of the
theoretically possible 656 segments (86.7%) were included
in the analysis.
Image quality of low-dose CTCA was diagnostic in
566/569 (99.5%) segments in 39/41 (95%) of patients.
Three segments (two in segment 2, one in segment 7) were
not assessable because of motion artefacts. No stair-step
artefacts, image noise, severe vessel wall calcifications or
insufficient contrast attenuation rendering image quality
nondiagnostic were found.
Low-dose CTCA revealed stenoses of more than 50% in
101/566 segments (17.8%), corresponding to 58/123 coro-
nary arteries (47.2%) in 24/41 patients (59%). Twenty-four
of these stenoses were located in the LAD (41.4%), 17 in the
LCX (29.3%) and 17 in the RCA (29.3%).
When applying a cutoff of more than 75% for significant
stenoses, 68 segments (12.0%) were identified as stenotic
by low-dose CTCA, corresponding to 46 coronary arteries
(37.4%) in 23 patients (56%). Nineteen stenoses were
located in the LAD (41.3%), 13 in the LCX (28.3%) and 14
in the RCA (30.4%).
CMR
CMR was successfully performed in all patients without
complications. Image analysis revealed defects in 100/656
(15.2%) myocardial segments in 21/41 (51%) patients. Of
the 100 myocardial segments with perfusion defects, 30
(30%) were located in the LAD, 38 (38%) in the LCX and
32 (32%) in the RCA territory. Twenty patients (49%)
showed no perfusion abnormalities on CMR. Of the 41
patients, a total of 7 patients (17%) showed LGE. Of the 27
myocardial segments with LGE, 2 (7%) were located in the
LAD, 15 (56%) in the LCX and 10 (37%) in the RCA
territory.
Inter-reader variability
The κ values for the detection of coronary stenosis of more
than 50% and more than 75% with low-dose CTCA were
0.89 and 0.96, respectively, indicating excellent inter-
observer agreement.
The κ value for the detection of CAD using CMR was
0.81, indicating excellent inter-reader agreement.
Comparison of low-dose CTCA and CMR
Per artery analysis
Applying a cutoff for stenoses of more than 50%, 42/58
stenotic coronary arteries (72%) were associated with
defects in their corresponding territory according to CMR
(Fig. 2). Sixteen of 58 stenotic coronary arteries (28%)
were not associated with abnormalities on CMR (Fig. 3).
Five of 47 myocardial territories with perfusion defects
(11%) showed no coronary stenoses in the corresponding
arteries on low-dose CTCAwhen a threshold of more than
50% was applied.
For coronary stenoses of more than 75%, 35/46 stenotic
vessels (76%) on low-dose CTCA were associated with
defects in the corresponding territory on CMR (Fig. 2).
Eleven of 46 stenotic coronary arteries (24%) were not
Fig. 2 a Low-dose CTCA in a 70-year-old male patient showing a
significant stenosis (rated as causing more than 75% luminal
diameter narrowing) of the proximal segment of the left anterior
descending artery (arrowhead). b Perfusion CMR during rest
demonstrates a normal signal in the myocardium. c Perfusion CMR
during adenosine-induced stress shows a perfusion deficit in the
subendocardium of the mid-ventricular septal wall, indicating
myocardial ischaemia
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associated with abnormalities on CMR. Twelve of 47
myocardial territories with perfusion defects (26%) showed
no coronary stenoses in the corresponding arteries on low-
dose CTCA when a threshold of more than 75% was
applied.
The sensitivity, specificity, NPV, PPV and accuracy of
low-dose CTCA for the detection of any myocardial
defects are given in Table 2, for coronary stenoses of more
than 50% and more than 75%.
Per patient analysis
For coronary stenoses of more than 50%, 26/30 patients
(86.7%) with stenotic coronary arteries on low-dose CTCA
had segments with perfusion defects in CMR. Four of the
30 patients (13.3%) showed coronary stenoses without
corresponding defects in CMR. Of the 12 patients without
significant stenoses on CTCA, 11 (91.7%) did not show
any abnormalities on CMR. One patient (8.3%) had
perfusion defects in the LAD territory (segments 8, 13
and 14) on CMR without corresponding stenosis in CTCA.
This patient had undergone percutaneous coronary inter-
vention (PCI) with stenting of the proximal LAD 1 year
before the study.
Applying a cutoff of more than 75%, 25/28 patients
(89.3%) with stenotic coronary arteries on low-dose CTCA
had segments showing perfusion defects on CMR. Of the
remaining 14 patients, 2 (14.3%) had defects on CMR
(Table 2).
The sensitivity, specificity, NPV, PPV and accuracy of
low-dose CTCA for the detection of any myocardial
defects are given in Table 2, for coronary stenoses of more
than 50% and more than 75%.
When late gadolinium enhancement imaging was not
considered, specificity and PPV decreased by 8% and 9%,
respectively, for more than 50% stenosis and by 8% each
for more than 75% stenosis, while sensitivity and NPV
remained unchanged (100%).
Discussion
This study is the first to demonstrate that low-dose CTCA
is excellent for ruling out haemodynamically relevant CAD
as compared with CMR. On the other hand, an abnormal
Fig. 3 a Low-dose CTCA in a 51-year-old male patient showing a
significant stenosis (rated as causing more than 50% luminal
diameter narrowing) of the middle segment of the left anterior
descending artery (arrowhead). Perfusion CMR during rest (b) and
during adenosine-induced stress (c) shows normal myocardial
perfusion indicating no ischaemia or scarring
Table 2 Accuracy of low-dose CTCA for the detection of perfusion defects as determined by perfusion CMR
Sensitivity Specificity PPV NPV Accuracy
(CI; n) (CI; n) (CI; n) (CI; n) (CI; n)
Per artery analysis
>50% stenosis 89% (79–99; 42/47) 79% (69–89; 60/76) 72% (60–85; 42/58) 92% (85–100; 60/65) 83% (76–90; 102/123)
>75% stenosis 74% (61–88; 35/47) 86% (77–94; 65/76) 76% (63–90; 35/46) 84% (76–93; 65/77) 81% (73–88; 100/123)
Per patient analysis
>50% stenosis 100% (98–100; 21/21) 85% (67–100; 17/20) 88% (72–100; 21/24) 100% (97–100; 17/17) 93% (83–100; 38/41)
>75% stenosis 100% (98–100; 21/21) 90% (74–100; 18/20) 91% (78–100; 21/23) 100% (97–100; 18/18) 95% (87–100; 39/41)
NPV negative predictive value, PPV positive predictive value, CI 95% confidence interval
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low-dose CTCA study is a poor predictor of the functional
relevance of the disease.
Coronary morphology and myocardial function
Previous reports have demonstrated that the anatomical
assessment of a coronary stenosis as determined by ICA
correlates only poorly with the haemodynamic significance
of the stenosis [27]. Although ICA is the most accurate
technique for imaging luminal morphology, it does not
reflect the haemodynamic impairment of blood flow to the
myocardium, as it does not account for the effects of
collateral circulation, the mass of viable myocardium, the
shape and length of stenosis, the inflow and outflow
configuration and the haemodynamic features of blood
flow [28]. In addition, the diffuseness of atherosclerosis,
often resulting in disease proximal and distal to the major
lesion, may lead to an underestimation of the extent and
severity of coronary atherosclerosis. Similar results to
those from ICA could also be demonstrated for low-dose
CTCA in this study. Being an entirely morphological
imaging tool, CTCA insufficiently predicted the haemo-
dynamic significance of a coronary stenosis on myocardial
perfusion as demonstrated by the PPV. On the other hand,
our study results indicate that, in the same patient cohort,
low-dose CTCA is an adequate tool for excluding
functionally relevant CAD, as shown by the excellent
NPV in this study.
Altogether, this study confirms previous studies employ-
ing nuclear tests [18, 26, 29–31] and ICA [28, 32] in
comparison with CTCA, while extending the results to the
low-dose technique for CTCA and for the first time using
CMR as the standard of reference.
An important aspect when correlating coronary obstruc-
tion with myocardial perfusion is related to the cutoff value
for defining the “significance” of a stenosis. Previous studies
used various definitions, such as a 50% area stenosis [26], a
50% diameter or a 75% diameter stenosis [31]. In this study,
we used both a 50% and a 75% diameter stenosis as cutoff
values for defining stenosis at low-dose CTCA.
As expected, shifting the cutoff diameter stenosis from
50% to 75% led to an improvement in the specificity and
PPVof low-dose CTCA for predicting myocardial ischaemia
through a reduction of “false-positive” stenoses with CTCA:
the higher the stenosis, the higher the likelihood of flow
disturbances in the corresponding myocardial territory. On
the other hand, the sensitivity and NPV decreased because
“false-negative” stenoses of between 50 and 75% diameter
narrowing leading to perfusion defects were missed.
Clinical implications
Based on our study results and according to the literature
[18, 26, 28–31], CTCA appears to be best suited as an
effective test for ruling out functionally relevant CAD.
Those patients with suspected CAD and no or minimal
coronary atherosclerosis on CTCA do not need further
investigation, as previously also demonstrated with regard
to their midterm outcome [33, 34]. On the other hand,
patients with morphologically obstructive CAD on CTCA
appear to be best investigated using a combined approach
including a functional test such as nuclear stress testing,
stress echocardiography or CMR. Considering the radia-
tion dose applied to patients undergoing cardiac SPECT
[35], CMR should be considered the preferred imaging
investigation.
The advantage of a combined evaluation using low-dose
CTCA and CMR lies in the very low radiation exposure to
the patients, a total of 1–4 mSv [14, 15, 17]. Reviewing the
literature reveals that studies on radiation exposure caused
by catheter coronary angiography are conspicuously rare.
Depending on the studies, effective doses ranged from 4 to
22 mSv for diagnostic invasive procedures [36]. Previous
single-source 64-slice CT coronary angiography studies
have reported estimated radiation doses of up to 21 mSv
without the use of the ECG pulsing technique [9]. On the
other hand, Hausleiter et al. [37] reported a mean effective
dose of 15 mSv for single-source 64-slice CT coronary
angiography without and 9 mSv with the use of ECG
pulsing, the latter being comparable to those of dual-source
CTCA employing retrospective ECG gating [13]. All of
these radiation dose values are higher when compared with
the CTCA approach with prospective ECG triggering.
Study limitations
First, ICA was not available in all patients from this study
to verify the findings from low-dose CTCA. On the other
hand, the accuracy of low-dose CTCA has been previously
documented [17], and the aim of this study was to assess
the impact of low-dose CTCA findings on myocardial
perfusion. Second, low-dose CTCA is feasible only in
patients with regular heart rates, thus limiting the
application of the technique to a broader patient population.
Third, CMR images were not analysed using quantitative
measures. In most studies analysing CMR images, how-
ever, evaluation of perfusion defects is done on a purely
visual basis [1, 24, 25, 38–41]. Fourth, using strict
inclusion criteria, 13% of the consecutive patients had to
be excluded due to CMR exclusion criteria. Fifth, no
separate comparisons between CT and CMR were
performed in respect to coronary morphology as assessed
with both methods separately. Similarly, there are no data
on perfusion imaging using CT. Sixth, 5/53 patients (9%)
were excluded from low-dose CTCA because of high heart
rate. This number theoretically could have been lowered by
administering beta-blockers prior to CT, because beta-
receptor antagonists reduce the average and the variability
of heart rate [42]. Seventh, we must state that the pretest
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probability was intermediate to high and therefore results
may be different in “real-world” patients having lower
pretest probability. Additionally, perfusion deficits may
also occur in microvascular disease and may alter results of
this comparison. Finally, the assessment of coronary
stenoses on low-dose CTCA using two cutoff values may
have been inaccurate, particularly considering the still
limited spatial resolution of CTCA in comparison with
ICA.
Conclusion
Low-dose CTCA is a reliable tool for identifying patients
with no functionally relevant CAD. On the other hand, an
abnormal low-dose CTCA study appears to be a poor
predictor of myocardial ischaemia.
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